Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SummitReheis is a leading global provider of specialty chemical solutions, primarily serving the personal care and healthcare industries. The company is the preeminent manufacturer of aluminum and zirconium-based active ingredients, holding a dominant market share in the global antiperspirant actives market. In addition to its personal care portfolio, SummitReheis produces high-quality aluminum and magnesium-based compounds used as active pharmaceutical ingredients in antacids and as critical adjuvants for vaccine stabilization. The company was acquired by Elementis in 2017 for $460 million, significantly expanding the parent company's footprint in the high-growth personal care sector. Today, it operates as a key business unit within Elementis, maintaining manufacturing facilities across North America, Europe, and Asia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SummitReheis.